Medical Condition

overweight

Total Trials

12

Recruiting Now

12

Trial Phases

Phase 1, Phase 3, Phase 2

ClinicalMetric tracks all active clinical trials for overweight sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — overweight Clinical Trials

How many clinical trials are currently recruiting for overweight?

ClinicalMetric currently tracks 12 actively recruiting clinical trials for overweight, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for overweight?

overweight research spans Phase 1 (4 trials), Phase 2 (1 trial), Phase 3 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a overweight clinical trial?

Eligibility criteria for overweight trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 3

Top Sponsors

Novo Nordisk A/S 3 trials

Shanghai World Leader Pharmaceutical Co., Ltd. 1 trial

Pfizer 1 trial

Shih Chien Huang 1 trial

Boehringer Ingelheim 1 trial

Recruiting Clinical Trials

NCT07465965 Phase 1

Recruiting

A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults

Shanghai World Leader Pharmace...

View Trial →

NCT07792954 Phase 3

Recruiting

A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Enrollment

300 pts

Location

United States, Austr...

Effects of GLP-1 Formula on GLP-1 and Glucose Regulation

A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in People Living With Overweight or Obesity

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Enrollment

950 pts

Location

United States, Canad...

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Eli Lilly and Company

View Trial →

NCT05942287

Recruiting

The Effect of Obesity and Weight Loss in Heart Failure With Reduced Ejection Fraction.

Enrollment

110 pts

Location

Jersey, United Kingd...

Optimization of Chrononutrition to Reduce the Risk of Disease in Shift Workers

Salk Institute for Biological ...

View Trial →

NCT07447362

Recruiting

Clinical Management of Cardiovascular Risk Factors in Adult Patients: A Before-and-After Interventional Study

Universidad Católica San Anton...

View Trial →

NCT07557953 Phase 1

Recruiting

A Research Study Looking Into How Cagrilintide Influences Food Intake and Appetite in People With Overweight or Obesity

A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication

Related Conditions

obesity (11) obstructive sleep apnoea (1) diabetes mellitus type 2 (1) heart failure (1) heart failure with reduced ejection fraction (1) night shift work (1) time restricted eating (1) cardiovascular risk factors (1) hypertension (1) dyslipidemia (1) type 2 diabetes mellitus (1) tobacco use (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology